Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
United Parcel Service
UPS
$88.8B
| $90.4M | 0.13% |
842,200
-461,600
| -35% | -$50.4M |
|
177
Toyota
TM
$225B
| $90.3M | 0.13% |
831,000
-140,800
| -14% | -$16.2M |
|
178
Manhattan Associates
MANH
$11.4B
| $90.2M | 0.13% |
1,733,760
+107,800
| +7% | +$5.43M |
|
179
Regeneron Pharmaceuticals
REGN
$82.1B
| $89.9M | 0.13% |
232,076
-18,484
| -7% | -$6.85M |
|
180
Toronto Dominion Bank
TD
$201B
| $89.6M | 0.13% |
1,788,300
-39,300
| -2% | -$2.01M |
|
181
PG&E
PCG
$38.1B
| $89.2M | 0.12% |
1,343,700
+123,100
| +10% | +$7.85M |
|
|
PF
182
DELISTED
Pinnacle Foods, Inc.
PF
| $89M | 0.12% |
1,538,500
+598,537
| +64% | +$33.2M |
|
183
S&P Global
SPGI
$120B
| $89M | 0.12% |
680,400
-566,400
| -45% | -$70.4M |
|
184
Molson Coors Class B
TAP
$7.83B
| $88.3M | 0.12% |
922,200
+830,800
| +909% | +$81.1M |
|
185
Teradata
TDC
$2.5B
| $88M | 0.12% |
2,826,800
-299,100
| -10% | -$9.04M |
|
186
Huntington Ingalls Industries
HII
$12.9B
| $87.3M | 0.12% |
436,200
+3,000
| +0.7% | +$610K |
|
187
Edwards Lifesciences
EW
$54B
| $87.1M | 0.12% |
2,778,900
+183,300
| +7% | +$5.74M |
|
|
WCG
188
DELISTED
Wellcare Health Plans, Inc.
WCG
| $86.7M | 0.12% |
618,300
+377,900
| +157% | +$53.8M |
|
189
Children's Place
PLCE
$56.3M
| $86.4M | 0.12% |
720,060
+211,700
| +42% | +$22.3M |
|
|
ESRX
190
DELISTED
Express Scripts Holding Company
ESRX
| $86.2M | 0.12% |
1,308,239
+1,294,400
| +9,353% | +$89.1M |
|
191
Southwest Airlines
LUV
$22.3B
| $86M | 0.12% |
1,599,300
-1,007,500
| -39% | -$54.2M |
|
|
INFO
192
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $86M | 0.12% |
2,048,966
+679,800
| +50% | +$26.9M |
|
193
Xerox
XRX
$423M
| $85.9M | 0.12% |
2,926,072
-1,404,968
| -32% | -$40.6M |
|
|
DATA
194
DELISTED
Tableau Software, Inc.
DATA
| $84.4M | 0.12% |
1,703,500
+968,400
| +132% | +$47.9M |
|
195
Live Nation Entertainment
LYV
$42.7B
| $84.1M | 0.12% |
2,769,366
-304,895
| -10% | -$8.73M |
|
196
PLDT
PHI
$4.23B
| $84.1M | 0.12% |
2,614,800
-69,600
| -3% | -$2.08M |
|
|
MGLN
197
DELISTED
Magellan Health Services, Inc.
MGLN
| $83.8M | 0.12% |
1,213,099
+122,999
| +11% | +$8.98M |
|
|
ABMD
198
DELISTED
Abiomed Inc
ABMD
| $83.7M | 0.12% |
668,700
+144,800
| +28% | +$16.8M |
|
199
Devon Energy
DVN
$49.9B
| $83.7M | 0.12% |
2,006,000
-1,660,200
| -45% | -$73M |
|
200
Monster Beverage
MNST
$89.2B
| $83.3M | 0.12% |
7,216,800
+5,402,800
| +298% | +$60.4M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.